Rapid decline of humoral response to two doses of BNT162b2 vaccine in patients with solid cancer after six months: The urgent need of the additional dose!-Reference-Cited by-同舟云学术

Rapid decline of humoral response to two doses of BNT162b2 vaccine in patients with solid cancer after six months: The urgent need of the additional dose!

Published:2022-04 Issue: Volume:165 Page:169-173
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Di Noia Vincenzo^ORCID,Pimpinelli Fulvia,Renna Davide,Maccallini Maria T.^ORCID,Gariazzo Ludovica,Cosimati Antonella,Campo Flaminia,Sperandio Eleonora,Pellini Raul,Giannarelli Diana,Cognetti Francesco

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference4 articles.

1. Immunogenicity and safety of COVID-19 vaccine BNT162b2 for patients with solid cancer: a large cohort prospective study from a single institution;Di Noia;Clin Cancer Res,2021

2. Clinical characteristics limiting the durability of humoral response to BNT162b2 in patients with solid cancer;Di Noia;Ann Oncol Nov,2021

3. SARS-CoV-2 vaccine protection and deaths among US veterans during 2021;Cohn;Science,2021

4. The first report on coronavirus disease 2019 (COVID-19) vaccine refusal by patients with solid cancer in Italy: early data from a single-institute survey;Di Noia;Eur J Cancer,2021

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination of Adults With Cancer: ASCO Guideline;Journal of Clinical Oncology;2024-05-10

2. The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China;Vaccines;2023-12-04

3. Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short Review;Vaccines;2023-05-11

4. AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants;European Journal of Cancer;2023-03

5. Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?;European Journal of Cancer;2022-11